The effect of antipyrine and rifampin on the metabolism of diazepam.
The elimination of diazepam and antipyrine and the urinary excretion of their metabolites were investigated in 21 healthy volunteers before and after 7 days of administration of antipyrine, 1200 mg, and rifampin, 600 or 1200 mg. After administration of antipyrine and rifampin in two doses, antipyrine total body clearance increased by 53% and 60% or 98%, respectively. The clearance to metabolite showed a preferential induction of the norantipyrine pathway with different proportions after antipyrine and rifampin; rifampin, 1200 mg, also enhanced the 4-hydroxyantipyrine pathway further. After antipyrine, diazepam total body clearance was increased by 102%, affecting all metabolic pathways to a similar extent. After rifampin in both doses, diazepam total body clearance rose equally to 300% and desmethyl- and 3-hydroxydiazepam metabolic clearance to 400%. Therefore rifampin preferentially affects norantipyrine or desmethyl- and 3-hydroxydiazepam metabolic formation, suggesting induction of different (iso)zymes of cytochrome P-450.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D000328:Adult; D000983:Antipyrine / Q000378:metabolism / Q000494:pharmacology*; D003975:Diazepam / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000201:enzymology; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D012293:Rifampin / Q000494:pharmacology*
D015065:17-Hydroxycorticosteroids; C001380:6 beta-hydroxycortisol; D003975:Diazepam; D000983:Antipyrine; D012293:Rifampin; D006854:Hydrocortisone